Fonte: Biochemical Pharmacology. Unidade: FMRP
Assuntos: RIM, HIPERGLICEMIA, ESTRESSE OXIDATIVO, ESPÉCIES REATIVAS DE OXIGÊNIO
ABNT
COSTA, Rafael Menezes da et al. Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: possible involvement of O-GlcNAcylation. Biochemical Pharmacology, v. 220, p. 1-10, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2023.115982. Acesso em: 18 nov. 2024.APA
Costa, R. M. da, Dias, M. C., Alves, J. V., Silva, J. L. M., Rodrigues, D., Silva, J. F. da, et al. (2024). Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: possible involvement of O-GlcNAcylation. Biochemical Pharmacology, 220, 1-10. doi:10.1016/j.bcp.2023.115982NLM
Costa RM da, Dias MC, Alves JV, Silva JLM, Rodrigues D, Silva JF da, Francescato HDC, Ramalho LNZ, Coimbra TM, Passaglia R de CAT. Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: possible involvement of O-GlcNAcylation [Internet]. Biochemical Pharmacology. 2024 ; 220 1-10.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bcp.2023.115982Vancouver
Costa RM da, Dias MC, Alves JV, Silva JLM, Rodrigues D, Silva JF da, Francescato HDC, Ramalho LNZ, Coimbra TM, Passaglia R de CAT. Pharmacological activation of nuclear factor erythroid 2-related factor-2 prevents hyperglycemia-induced renal oxidative damage: possible involvement of O-GlcNAcylation [Internet]. Biochemical Pharmacology. 2024 ; 220 1-10.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.bcp.2023.115982